• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNM 分期为 I 期的结直肠癌复发的危险因素。

Risk factors of recurrence in TNM stage I colorectal cancer.

作者信息

Paik Jin-Hee, Ryu Chun-Geun, Hwang Dae-Yong

机构信息

Department of Surgery, Colorectal Cancer Center, Konkuk University Medical Center, Seoul, Korea.

Department of Surgery, Konkuk University School of Medicine, Seoul, Korea.

出版信息

Ann Surg Treat Res. 2023 May;104(5):281-287. doi: 10.4174/astr.2023.104.5.281. Epub 2023 Apr 28.

DOI:10.4174/astr.2023.104.5.281
PMID:37179701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10172029/
Abstract

PURPOSE

TNM stage I colorectal cancer (CRC) can recur, although the recurrence rate is low. Few studies have evaluated the risk factors for TNM stage I CRC recurrence. This study aimed to evaluate the TNM stage I CRC recurrence rate, as well as risk factors for recurrence.

METHODS

In this retrospective study, we reviewed the database of patients who had undergone surgery for TNM stage I CRC between November 2008 and December 2014 without receiving neoadjuvant therapy or transanal excision for rectal cancer. Our analysis included 173 patients. Primary lesions were found in the colon of 133 patients and in the rectum of 40 patients.

RESULTS

The CRC recurrence rate was 2.9% (5 out of 173 patients). For colon cancer patients, tumor size was not associated with higher recurrence risk (P = 0.098). However, for rectal cancer patients, both tumor size (≥3 cm) and T stage were associated with higher recurrence risk (P = 0.046 and P = 0.046, respectively). Of the 5 recurrent cases, 1 patient exhibited disease progression despite treatment, 1 patient maintained stable disease status after recurrence treatment, and 3 patients had no evidence of a tumor after recurrence treatment.

CONCLUSION

Our findings suggest that tumor size and T stage are predictors of stage I rectal cancer recurrence, and careful monitoring and follow-up of patients with larger tumors may be warranted.

摘要

目的

TNM 分期为 I 期的结直肠癌(CRC)虽复发率低,但仍会复发。很少有研究评估 TNM 分期为 I 期 CRC 复发的危险因素。本研究旨在评估 TNM 分期为 I 期 CRC 的复发率及复发危险因素。

方法

在这项回顾性研究中,我们查阅了 2008 年 11 月至 2014 年 12 月期间接受 TNM 分期为 I 期 CRC 手术且未接受新辅助治疗或直肠癌经肛门切除术的患者数据库。我们的分析纳入了 173 例患者。133 例患者的原发灶位于结肠,40 例患者的原发灶位于直肠。

结果

CRC 复发率为 2.9%(173 例患者中有 5 例)。对于结肠癌患者,肿瘤大小与较高的复发风险无关(P = 0.098)。然而,对于直肠癌患者,肿瘤大小(≥3 cm)和 T 分期均与较高的复发风险相关(分别为 P = 0.046 和 P = 0.046)。在 5 例复发病例中,1 例患者尽管接受了治疗仍出现疾病进展,1 例患者复发治疗后疾病状态保持稳定,3 例患者复发治疗后无肿瘤证据。

结论

我们的研究结果表明,肿瘤大小和 T 分期是 I 期直肠癌复发的预测因素,对于肿瘤较大的患者可能需要进行仔细的监测和随访。

相似文献

1
Risk factors of recurrence in TNM stage I colorectal cancer.TNM 分期为 I 期的结直肠癌复发的危险因素。
Ann Surg Treat Res. 2023 May;104(5):281-287. doi: 10.4174/astr.2023.104.5.281. Epub 2023 Apr 28.
2
[Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].经肛门全直肠系膜切除术与腹腔镜直肠系膜切除术治疗中低位直肠癌的安全性及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jun 25;25(6):522-530. doi: 10.3760/cma.j.cn441530-20210811-00321.
3
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
4
Elevated tumor-to-liver uptake ratio (TLR) from F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)示肿瘤与肝脏摄取比值(TLR)升高提示 IIA 期结直肠癌根治术后预后不良。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1958-1968. doi: 10.1007/s00259-017-3779-0. Epub 2017 Aug 15.
5
[Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].[Ⅲ期结肠癌中肿瘤结节TNM分期方法的预后价值及初步探索性研究]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Dec 25;22(12):1152-1158. doi: 10.3760/cma.j.issn.1671-0274.2019.12.010.
6
[Retrospective investigation of patients receiving additional surgery after endoscopic non-curative resection for early colorectal cancer].[早期结直肠癌内镜下非根治性切除术后接受额外手术患者的回顾性调查]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 May 25;23(5):486-491. doi: 10.3760/cma.j.cn.441530-20190612-00239.
7
Tumor Size >5 cm and Harvested LNs <12 Are the Risk Factors for Recurrence in Stage I Colon and Rectal Cancer after Radical Resection.肿瘤大小>5厘米且清扫淋巴结<12枚是I期结肠癌和直肠癌根治性切除术后复发的危险因素。
Cancers (Basel). 2021 Oct 21;13(21):5294. doi: 10.3390/cancers13215294.
8
Features of Late Recurrence Following Transanal Local Excision for Early Rectal Cancer.早期直肠癌经肛门局部切除术后迟发性复发的特征
Dis Colon Rectum. 2015 Nov;58(11):1041-7. doi: 10.1097/DCR.0000000000000456.
9
A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.II-III期结直肠癌患者肿瘤复发的预测模型:从机器学习模型到基因组分析
Biomedicines. 2022 Feb 1;10(2):340. doi: 10.3390/biomedicines10020340.
10
Periocular Squamous Cell Carcinoma: TNM Staging and Recurrence.眼附属器鳞状细胞癌:TNM 分期与复发。
Ophthalmology. 2015 Jul;122(7):1512-6. doi: 10.1016/j.ophtha.2015.04.002. Epub 2015 May 9.

引用本文的文献

1
Establishing high risk factors for recurrence in stage I/II colorectal cancer: a metropolitan perspective.确定I/II期结直肠癌复发的高危因素:大城市视角
World J Surg Oncol. 2025 Jun 18;23(1):241. doi: 10.1186/s12957-025-03823-0.
2
Risk factors for recurrence in stage I colorectal cancer after curative resection: a systematic review and meta-analysis.I期结直肠癌根治性切除术后复发的危险因素:一项系统评价和荟萃分析。
Ann Surg Treat Res. 2025 Jan;108(1):39-48. doi: 10.4174/astr.2025.108.1.39. Epub 2025 Jan 7.
3
Low muscle mass-to-fat ratio is an independent factor that predicts worse overall survival and complications in patients with colon cancer: a retrospective single-center cohort study.

本文引用的文献

1
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019.韩国癌症统计数据:2019 年的发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2022 Apr;54(2):330-344. doi: 10.4143/crt.2022.128. Epub 2022 Mar 16.
2
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.结肠癌临床实践指南(2021 年第 2 版),NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Mar 2;19(3):329-359. doi: 10.6004/jnccn.2021.0012.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
低肌肉质量与脂肪比例是预测结肠癌患者总体生存率和并发症更差的独立因素:一项回顾性单中心队列研究。
Ann Surg Treat Res. 2024 Aug;107(2):68-80. doi: 10.4174/astr.2024.107.2.68. Epub 2024 Jul 30.
4
Current Applications and Future Directions of Circulating Tumor Cells in Colorectal Cancer Recurrence.循环肿瘤细胞在结直肠癌复发中的当前应用及未来方向
Cancers (Basel). 2024 Jun 24;16(13):2316. doi: 10.3390/cancers16132316.
5
National cancer screening program for colorectal cancer in Korea.韩国的国家结直肠癌筛查计划。
Ann Surg Treat Res. 2023 Dec;105(6):333-340. doi: 10.4174/astr.2023.105.6.333. Epub 2023 Nov 29.
6
Exploring the role of copine 1 in human colorectal cancer: investigating its association with tumorigenesis and metastasis.探索Copine 1在人类结直肠癌中的作用:研究其与肿瘤发生和转移的关联。
Ann Surg Treat Res. 2023 Dec;105(6):385-395. doi: 10.4174/astr.2023.105.6.385. Epub 2023 Nov 29.
7
Weighing the benefits of lymphadenectomy in early-stage colorectal cancer.权衡早期结直肠癌淋巴结清扫术的益处。
Ann Surg Treat Res. 2023 Nov;105(5):245-251. doi: 10.4174/astr.2023.105.5.245. Epub 2023 Oct 31.
8
Real-world survival after colorectal surgery for malignancy in Korean patients with chronic kidney disease: an analysis of Korean healthcare big data, 2002-2019.韩国慢性肾病患者结直肠癌手术后的真实世界生存率:2002 - 2019年韩国医疗大数据分析
Ann Surg Treat Res. 2023 Nov;105(5):281-289. doi: 10.4174/astr.2023.105.5.281. Epub 2023 Oct 31.
9
Harnessing Minimal Residual Disease as a Predictor for Colorectal Cancer: Promising Horizons Amidst Challenges.利用微小残留病灶作为结直肠癌预测指标:挑战与希望并存。
Medicina (Kaunas). 2023 Oct 23;59(10):1886. doi: 10.3390/medicina59101886.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Pattern, Stage, and Time of Recurrent Colorectal Cancer After Curative Surgery.根治性手术后复发性结直肠癌的模式、阶段和时间。
Clin Colorectal Cancer. 2019 Jun;18(2):e223-e228. doi: 10.1016/j.clcc.2019.01.003. Epub 2019 Jan 29.
5
Do Stage I Colorectal Cancers with Lymphatic Invasion Require a Different Postoperative Approach?Ⅰ期伴淋巴管浸润的结直肠癌是否需要不同的术后处理方式?
J Gastrointest Surg. 2019 Sep;23(9):1884-1892. doi: 10.1007/s11605-018-4054-9. Epub 2018 Dec 3.
6
Establishment of a 12-gene expression signature to predict colon cancer prognosis.建立一个用于预测结肠癌预后的12基因表达特征。
PeerJ. 2018 Jun 14;6:e4942. doi: 10.7717/peerj.4942. eCollection 2018.
7
Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection.Ⅰ期结直肠癌根治术后复发的预测列线图
Clin Colorectal Cancer. 2018 Sep;17(3):e513-e518. doi: 10.1016/j.clcc.2018.03.011. Epub 2018 Mar 29.
8
The prognostic implications of primary tumor location on recurrence in early-stage colorectal cancer with no associated risk factors.在无相关危险因素的早期结直肠癌中,原发性肿瘤位置对复发的预后影响。
Int J Colorectal Dis. 2018 Jun;33(6):719-726. doi: 10.1007/s00384-018-3031-9. Epub 2018 Mar 28.
9
Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?I期直肠癌局部切除或经肛门内镜显微手术与根治性切除的系统评价和Meta分析:一个真正的标准?
Crit Rev Oncol Hematol. 2017 Jun;114:43-52. doi: 10.1016/j.critrevonc.2017.03.008. Epub 2017 Apr 1.
10
Identification of Recurrence-Predictive Indicators in Stage I Colorectal Cancer: Reply.I期结直肠癌复发预测指标的鉴定:回复
World J Surg. 2017 Jun;41(6):1658-1659. doi: 10.1007/s00268-017-3994-7.